Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 2 34-2, 1996, Pages

  Lang, Charles H ^a   Cooney, Robert ^b   Vary, Thomas C ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

catecholamines; cytokines; glucose production; glucose utilization; liver; pyruvate dehydrogenase

Indexed keywords

ADRENALIN; CORTICOSTERONE; ESCHERICHIA COLI ENDOTOXIN; GLUCAGON; GLUCOSE; GLYCOGEN; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LACTIC ACID; NORADRENALIN; PYRUVATE DEHYDROGENASE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029771630     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.2.e309     Document Type: Article

References (35)

1. Ban, E., F. Haour, and R. Lenstra. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 4: 48-54, 1992.
2. Banks, W. A., L. Ortiz, S. R. Plotkin, and A. J. Kastin. Human interleukin (IL)-1α, marine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol. Exp. Ther. 259: 988-996, 1991.
3. Benveniste, E. N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263 (Cell Physiol. 32): C1-C16, 1992.
4. Conney, R., E. Owens, C. Jurasinski, K. Gray, J. Vannice, and T. Vary. Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E636-E641, 1994.
5. Cornell, R. P., and D. B. Schwartz. Central administration of interleukin 1 elicits hyperinsulinemia in rats. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol 25): R772-R777, 1989.
6. Dinarello, C. A. Interleukin-1 and interleukin-1 receptor antagonist Nutrition 11: 492-494, 1995.
7. Dripps, D. J., B. J. Brandhuber, R. C. Thompson, and S. P. Eisenberg. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266: 10331-10336, 1991.
8. Dunn, A. J. The role of interleukin-1 and tumor necrosis factor α in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29: 807-812, 1992
9. Ebisui, O., J. Fukata, N. Murakami, H. Kobayashi, H. Segawa, S. Muro, I. Hanaoka, Y. Naito, Y. Masui, Y. Ohmoto, H. Iinura, and K. Nakao. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E986-E992, 1994.
10. Fischer, E., M. A. Marano, K. J. Van Zee, C. S. Rock, A. S. Hawes, W. A. Thompson, L. DeForge, J. S. Kenney, D. G. Remick, D. C. Bloedow, R. C. Thompson, S. F. Lowry, and L. L. Moldawer. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89: 1551-1557, 1992.
11. Gabellec, M.-M., R. Griffais, G. Fillion, and F. Haour. Expression of interleukin 1α, interleukin 1β and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Mol Brain. Res. 31: 122-130, 1995.
12. Gemma, C., P. Ghezzi, and M. G. De Simoni. Activation of the hypothalamic serotoninergic system by central interleukin-1. Eur. J. Pharmacol. 209: 139-140, 1991.
13. Givalois, L., J. Dornand, M. Mekaouche, M. D. Solier, A. F. Bristow, G. Ixart, P. Siaud, I. Assenmacher, and G. Barhanel. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R164-R170, 1994.
14. Hagan, P., S. Poole, and A. F. Bristow. Endotoxin-stimulated production of rat hypothalamic interleukin-1β in vivo and in vitro, measured by specific immunoradiometric assay. J. Mol. Endocrinol. 11: 31-36, 1993.
15. Hargrove, D. M., G. J. Bagby, C. H. Lang, and J. J. Spitzer. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E629-E635, 1988.
16. Kakucska, I., Y, Qi, B. D. Clark, and R. M. Lechan. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133: 815-821, 1993.
17. Katsuura, G., P. E. Gottschall, R. R. Dahl, and A. Arimura. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology 122: 1773-1779, 1988.
18. Keepler, D., and K. Decker. Glycogen determination with amyloglucosidase. In: Methods of Enzymatic Analysis, edited by H. U. Bergmeyer. New York: Academic, 1974, p. 1127-1131.
19. Kent, S., R.-M. Bluthe, R. Dantzler, A. J. Hardwick, K. W. Kelley, N. J. Rothwell, and J. L. Vannice. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. USA 89: 9117-9120, 1992.
20. Lang, C. H., G. J. Bagby, and J. J. Spitzer. Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R471-R478, 1985.
21. Lang, C. H., P. E. Molina, K. A. Yousef, P. G. Tepper, and N. N. Abumrad. Role of IL-1α in central nervous system immunomodulation of glucoregulation. Brain Res. 624: 53-60, 1993.
22. Linthorst, A. C. E., C. Fachskamm, P. Muller-Preuss, F. Holsboer, and J. M. H. M. Reul. Effect of bacterial endotoxin and interleukin-1β on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 15: 2920-2934, 1995.
23. Mustafa, M. M., M. H. Lebel, O. Ramilo, K. D. Olsen, J. S. Reisch, B. Beutler, and G. H. McCracken. Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115: 208-211, 1989.
24. Nakamori, T., A. Morimoto, K. Yamaguchi, T. Watanabe, N. C. Long, and N. Murakami. Organum vasculosum laminae terminalis (OVLT) is a brain site to produce interleukin-1β during fever. Brain Res. 618: 155-159, 1993.
25. Ovadia, H., O. Abramsky, and J. Weidenfeld. Evidence of the involvement of the central adrenergic system in the febrile response induced by interleukin-1 in rats. J. Neuroimmunol. 25: 109-116, 1989.
26. Petit, F., A. Jarrous, R. D. Dickinson, P. E. Molina, N. N. Abumrad, and C. H. Lang. Contribution of central and peripheral adrenergic stimulation to IL-1α-mediated glucoregulation. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E49-E56, 1994.
27. Plata-Salaman, C. R., and J. M. H. French-Mullen. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1β.Physiol. Behav. 51: 1277-1279, 1992.
28. Rivier, C., W. Vale, and M. Brown. In the rats, interleukin-1α and -β stimulate adrenocorticotropin and catecholamine release. Endocrinology 125: 3096-3102, 1989.
29. Sharif, S. F., R. J. Hariri, V. A. Chang, P. S. Barie, R. S. Wang, and J. B. G. Ghajar. Human astrocyte production of tumor necrosis factor-α, interleukin-1β, and interleukin-6 following exposure of lipopolysaccharide endotoxin. Neurol Res. 15: 109-112, 1993.
30. Shintani, F., S. Kanba, T. Nakaki, M. Nibuya, N. Kinoshita, E. Suzuki, G. Yagi, R. Kato, and M. Asai. Interleukin-1 augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13: 3574-3581, 1993.
31. Steele, R. Influence of glucose loading and of injected insulin on hepatic glucose output. Ann. NY Acad. Sci. 82: 420-430, 1959.
32. Stith, R. D., and L. A. Templer. Peripheral endocrine and metabolic responses to centrally administered interleukin-1. Neuroendocrinology 60: 215-224, 1994.
33. Van Dam, A.-M., M. Brouns, S. Louisse, and F. Berkenbosch. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588: 291-296, 1992.
34. Vary, T. C., J. H. Siegel, T. Nakatani, T. Sato, and H. Aoyama. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am. J. Physiol 250 (Endocrinol. Metab. 13): E634-E640, 1986.
35. Virkamaki, A., and H. Yki-Jarvinen. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134: 2072-2078, 1994.